Most Read Articles
Elaine Soliven, 15 Jul 2019

Disease-free survival (DFS) at 3 years was comparable between patients with locally advanced gastric cancer who underwent laparoscopic distal gastrectomy and open distal gastrectomy, pointing to the noninferiority of the laparoscopic procedure to the open one, according to the CLASS-01* study.

18 Sep 2019
Mortality, length of stay (LOS) and hospital charges are significantly higher in chronic liver disease (CLD) patients with fractures, a recent study has shown. These findings are also associated with increased infection, bleeding and poorer wound healing.
01 Aug 2017
New drug applications approved by US FDA as of 16 - 30 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
07 Jun 2019
Gastro-oesophageal reflux disease (GERD) is common among obese patients qualified for bariatric surgery, underscoring the need for preoperative endoscopic assessment, a recent study has shown.

Eating red, processed meats does not increase risk of CD recurrence

13 Jul 2019

The consumption of red and processed meats does not seem to affect the likelihood of symptom relapse among Crohn’s disease (CD) patients in relapse, reports a recent study.

Researchers randomly assigned adults with CD to either a high- (≥2 servings per week; n=118; median age, 37.0 years; 74.6 percent female) or low- (≤1 serving per month; n=96; median age, 35.0 years; 80 percent female) red and processed meat diet. All participants were in remission and reported consumption levels at least once weekly. The study’s primary outcome was relapse in CD, defined as an increase in CD disease activity index scores or the need for surgery or new medication.

Symptomatic relapse of CD was detected in 62 percent of the participants, while 42 percent and 35 percent had moderate-to-severe or persistent recurrence, respectively. There were no significant differences in the unadjusted time to symptomatic relapse, time to moderate-to-severe symptomatic relapse or time to persistent relapse between the different study arms.

Stratified Cox regression analysis further showed that there was no significant link between consumption of red and processed meats and the likelihood of symptomatic relapse. However, baseline nutrient intake was significantly correlated with the risk of symptomatic relapse (hazard ratio, 13.46, 95 percent CI, 1.22–148.45; p=0.03).

“In this study, participants in the low-meat group reported consuming two or more servings of red and/or processed meat far less frequently than those in the high-meat group. Additionally, the low-meat group significantly decreased their average weekly red meat consumption during the study,” said researchers.

“Despite these clear differences in diets, there were no statistically significant differences in time to relapse for any of the outcomes, suggesting that reduction of red and processed meats does not reduce the risk of symptomatic CD relapse in patients with quiescent disease,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 15 Jul 2019

Disease-free survival (DFS) at 3 years was comparable between patients with locally advanced gastric cancer who underwent laparoscopic distal gastrectomy and open distal gastrectomy, pointing to the noninferiority of the laparoscopic procedure to the open one, according to the CLASS-01* study.

18 Sep 2019
Mortality, length of stay (LOS) and hospital charges are significantly higher in chronic liver disease (CLD) patients with fractures, a recent study has shown. These findings are also associated with increased infection, bleeding and poorer wound healing.
01 Aug 2017
New drug applications approved by US FDA as of 16 - 30 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
07 Jun 2019
Gastro-oesophageal reflux disease (GERD) is common among obese patients qualified for bariatric surgery, underscoring the need for preoperative endoscopic assessment, a recent study has shown.